Sionna Therapeutics, Inc. (SION) Deep Dive Video

Summary

Sionna is a high-stakes cystic fibrosis challenger: a cash-rich but pre-revenue biotech whose NBD1-stabilizing platform could disrupt Vertex—or collapse on pivotal clinical data.

View SION stock page · Read the SION research report

Loading the video player…